FDA expands emergency use of Gilead’s remdesivir in hospitalized COVID-19 patients

August 30, 2020 E Jazz Reporter

Gilead Inc said on Friday the U.S. Food and Drug Administration expanded the emergency use authorization of its experimental antiviral COVID-19 treatment, remdesivir, to allow its use in all hospital…
Read More

← Rockets Want NBA To Investigate Dennis Schroder Low Blow On P.J. Tucker Following Ejections
YFI price soars to $38.8K hitting $1B market cap — can it go higher? →